These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 17117335)

  • 1. [Treatment adherence in schizophrenia. A comparison between patient's, relative's and psychiatrist's opinions].
    Giner J; Cañas F; Olivares JM; Rodriguez A; Burón JA; Rodríguez-Morales A; Roca M
    Actas Esp Psiquiatr; 2006; 34(6):386-92. PubMed ID: 17117335
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Assessment of therapeutic adherence using questionnaires in patients with schizophrenia].
    István B; Agnes M
    Psychiatr Hung; 2006; 21(6):430-6. PubMed ID: 17438660
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Therapeutic alliance, a stake in schizophrenia].
    Charpentier A; Goudemand M; Thomas P
    Encephale; 2009 Feb; 35(1):80-9. PubMed ID: 19250998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survey of medication adherence in patients with schizophrenia--Korean ADHES data.
    Kim SW; Yoon JS; Choi SK
    Hum Psychopharmacol; 2006 Dec; 21(8):533-7. PubMed ID: 17133616
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Compliance in the treatment of schizophrenia--project ADHES (the renewed results)].
    Chadzyńska M; Meder J; Tyszkowska M
    Psychiatr Pol; 2008; 42(4):561-70. PubMed ID: 19189600
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Attitudes towards long-acting depot antipsychotics: a survey of patients, relatives and psychiatrists.
    Jaeger M; Rossler W
    Psychiatry Res; 2010 Jan; 175(1-2):58-62. PubMed ID: 20004980
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Substance abuse and the management of medication nonadherence in schizophrenia.
    Wilk J; Marcus SC; West J; Countis L; Hall R; Regier DA; Olfson M
    J Nerv Ment Dis; 2006 Jun; 194(6):454-7. PubMed ID: 16772865
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Schizophrenia: attitudes of patients and professional carers towards the illness and antipsychotic medication.
    Rettenbacher MA; Burns T; Kemmler G; Fleischhacker WW
    Pharmacopsychiatry; 2004 May; 37(3):103-9. PubMed ID: 15138893
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [What information do patients with schizophrenia have about their illness and treatment?].
    Ferreri M; Rouillon F; Nuss P; Bazin N; Farah S; Djaballah K; Gerard D
    Encephale; 2000; 26(5):30-8. PubMed ID: 11192802
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical study of drug compliance in long-term treatment for schizophrenia].
    Waseda T
    Seishin Shinkeigaku Zasshi; 1998; 100(5):261-90. PubMed ID: 9695687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [What impedes discharge support for persons with schizophrenia in psychiatric hospitals?].
    Ikebuchi E; Satoh S; Anzai N
    Seishin Shinkeigaku Zasshi; 2008; 110(11):1007-22. PubMed ID: 19202923
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Partial compliance with antipsychotic medication is common in patients with schizophrenia.
    Rummel-Kluge C; Schuster T; Peters S; Kissling W
    Aust N Z J Psychiatry; 2008 May; 42(5):382-8. PubMed ID: 18473256
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Results of a Polish national survey--physician's opinions on the physical health of schizophrenic patients].
    Kiejna A; Czernikiewicz A; Adamowski T
    Psychiatr Pol; 2009; 43(6):761-73. PubMed ID: 20209887
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Relatives' beliefs and attitudes towards schizophrenia: an epidemiological investigation].
    Sağduyu A; Aker T; Ozmen E; Uğuz S; Ogel K; Tamar D
    Turk Psikiyatri Derg; 2003; 14(3):203-12. PubMed ID: 14569471
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of subjective treatment satisfaction with antipsychotics in schizophrenia patients.
    Fujikawa M; Togo T; Yoshimi A; Fujita J; Nomoto M; Kamijo A; Amagai T; Uchikado H; Katsuse O; Hosojima H; Sakura Y; Furusho R; Suda A; Yamaguchi T; Hori T; Kamada A; Kondo T; Ito M; Odawara T; Hirayasu Y
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Apr; 32(3):755-60. PubMed ID: 18226436
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhancing medication adherence in people with schizophrenia: an international programme of research.
    Gray R; White J; Schulz M; Abderhalden C
    Int J Ment Health Nurs; 2010 Feb; 19(1):36-44. PubMed ID: 20074202
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between attitude toward medication and neurocognitive function in schizophrenia.
    Kim SW; Shin IS; Kim JM; Yang SJ; Shin HY; Yoon JS
    Clin Neuropharmacol; 2006; 29(4):197-205. PubMed ID: 16855421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A prototype approach toward antipsychotic medication adherence in schizophrenia.
    Freudenreich O; Tranulis C
    Harv Rev Psychiatry; 2009; 17(1):35-40. PubMed ID: 19205965
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The expert consensus guideline series: adherence problems in patients with serious and persistent mental illness.
    Velligan DI; Weiden PJ; Sajatovic M; Scott J; Carpenter D; Ross R; Docherty JP;
    J Clin Psychiatry; 2009; 70 Suppl 4():1-46; quiz 47-8. PubMed ID: 19686636
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Compliance in the treatment of schizophrenia -- results of an expert survey in Saxony and Saxony-Anhalt].
    Giessler A; Born A; Helm H; Puschner B; Becker T
    Psychiatr Prax; 2005 Oct; 32(7):349-57. PubMed ID: 16220419
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.